abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

11 Oct 2009

Author:
Sarah Boseley, Guardian [UK]

Haemophilia patients battle to sue firm that sold tainted drug in Asia

People with haemophilia in Taiwan are appealing a decision by the US courts that says they cannot sue a multi-national drugs firm [Cutter (part of Bayer)] in the US over allegations that they contracted HIV from contaminated blood products that the company knowingly dumped in Asia. The news comes as US pharmaceutical firms meet UK victims of the scandal, which affected nearly 1,200 people with haemophilia in Britain during the 1970s and 1980s....A spokesperson for Bayer said of the Taiwanese case: "Bayer is committed to the highest ethical standards, to promoting our medications responsibly and to providing life-saving therapies for the global haemophilia community."